It is time to conduct phase 3 clinical trials of sex hormones in MS

Abstract

Get full access to this article

View all access options for this article.

References

Clayton

Collins

FS.

Policy: NIH to balance sex in cell and animal studies. Nature 2014; 509(7500): 282–283.

Kim

Mangu

Hoffman

et al . Oestrogen receptor beta ligand acts on CD11c+ cells to mediate protection in experimental autoimmune encephalomyelitis. Brain 2018; 141(1): 132–147.

Voskuhl

Gold

SM.

Sex-related factors in multiple sclerosis susceptibility and progression. Nat Rev Neurol 2012; 8(5): 255–263.

Ziehn

Avedisian

Dervin

et al . Estriol preserves synaptic transmission in the hippocampus during autoimmune demyelinating disease. Lab Invest 2012; 92(8): 1234–1245.

Confavreux

Hutchinson

Hours

et al . Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 1998; 339(5): 285–291.

Sicotte

Liva

Klutch

et al . Treatment of multiple sclerosis with the pregnancy hormone estriol. Ann Neurol 2002; 52(4): 421–428.

Voskuhl

Wang

et al . Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: A randomised, placebo-controlled, phase 2 trial. Lancet Neurol 2016; 15(1): 35–46.

MacKenzie-Graham

Brook

Kurth

et al . Estriol- mediated neuroprotection in multiple sclerosis localized by voxel- based morphometry. Brain and Behavior. In press. DOI: 10.1002/brb3.1086

Engler-Chiurazzi

Brown

Povroznik

et al . Estrogens as neuroprotectants: Estrogenic actions in the context of cognitive aging and brain injury. Prog Neurobiol 2017; 157: 188–211.

10.

Pozzilli

De Giglio

Barletta

et al . Oral contraceptives combined with interferon β in multiple sclerosis. Neurol Neuroimmunol Neuroinflamm 2015; 2(4): e120.

11.

Vukusic

Ionescu

El-Etr

et al . The Prevention of Post-Partum Relapses with Progestin and Estradiol in Multiple Sclerosis (POPART’MUS) trial: Rationale, objectives and state of advancement. J Neurol Sci 2009; 286(1–2): 114–118.

12.

Hussain

Ghoumari

Bielecki

et al . The neural androgen receptor: A therapeutic target for myelin repair in chronic demyelination. Brain 2013; 136(Pt1): 132–146.

13.

Bove

Musallam

Healy

et al . Low testosterone is associated with disability in men with multiple sclerosis. Mult Scler 2014; 20(12): 1584–1592.

14.

Kurth

Luders

Sicotte

et al . Neuroprotective effects of testosterone treatment in men with multiple sclerosis. Neuroimage Clin 2014; 4: 454–460.

It is time to conduct phase 3 clinical trials of sex hormones in MS – Yes

Abstract

Get full access to this article

References